JULIA SUNG: Open Payments
NPI 1033609656 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 20 payments from 10 companies in 2025. Trend: 2023 $344 · 2024 $150 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 5 | $177 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| Hologic Sales and Service, LLC | 3 | $54 |
| Astellas Pharma US Inc | 2 | $33 |
| Exact Sciences Corporation | 2 | $32 |
| ABBVIE INC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| MILLICENT US INC | 1 | $19 |
| OptumHealth Care Solutions, LLC | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $15 |
Products named: ANNOVERA, GARDASIL 9, FETAL FIBRONECTIN ENZYME IMMUNOASSAY, Veozah, UBRELVY, Mirena, APTIMA, FEMLYV.
Industry payments across NV — which companies pay providers there.
